Back to Agenda
Session 2: Models for Implementing Platform Trials from the Lens of Patient Advocacy
Session Chair(s)
Abby Bronson, MBA
Vice President, Patient Advocacy and External Innovation
Edgewise Therapeutics, United States
Victoria Manax Rutson, MD
Chief Medical Officer
Pancreatic Cancer Action Network, United States
Patients and patient advocacy groups are often at the heart of creating patient-centric improvements in developing therapeutics for their community. Increasing patient groups are driving innovation through the platform trial concept, especially in rare diseases, where the efficiencies of platforms are needed. But what should an advocacy organization focus on as it explores the feasibility of a platform trial? Through a case study and discussion, this session will explore key topics to operationalize a platform trial as seen through the lens of patient advocacy.
Learning Objective : At the conclusion of this session, participants should be able to:- Understand some value drivers behind platform trial and who might benefit and thus contribute to start up
- Explore key operational considerations in the context of a platform trial - the complexities of data sharing and role of clinical trial network
- Discuss how an advocacy organization successfully put together all the pieces and started – Precision Promise Story
Speaker(s)
Speaker
Victoria Manax Rutson, MD
Pancreatic Cancer Action Network, United States
Chief Medical Officer
Value Drivers of Platform Trials - Who Might Fund?
Mark Trusheim, MS, MSc
Tufts Medical Center, United States
Strategic Director, NEWDIGS
Platform Trial Data Sharing Agreements
Sudheer Doss, PhD
Pancreatic Cancer Action Network, United States
Chief Data Officer and Head of Business Development
Speaker
Abby Bronson, MBA
Edgewise Therapeutics, United States
Vice President, Patient Advocacy and External Innovation
Have an account?